Demetrios T. Braddock

4.1k total citations · 2 hit papers
53 papers, 2.8k citations indexed

About

Demetrios T. Braddock is a scholar working on Molecular Biology, Genetics and Nephrology. According to data from OpenAlex, Demetrios T. Braddock has authored 53 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Genetics and 9 papers in Nephrology. Recurrent topics in Demetrios T. Braddock's work include Dermatological and Skeletal Disorders (12 papers), Parathyroid Disorders and Treatments (8 papers) and RNA Research and Splicing (7 papers). Demetrios T. Braddock is often cited by papers focused on Dermatological and Skeletal Disorders (12 papers), Parathyroid Disorders and Treatments (8 papers) and RNA Research and Splicing (7 papers). Demetrios T. Braddock collaborates with scholars based in United States, Germany and United Kingdom. Demetrios T. Braddock's co-authors include Ronald A. Albright, Raman Bahal, Frank J. Slack, W. Mark Saltzman, Varman T. Samuel, Alexander A. Svoronos, Hui‐Young Lee, Peter M. Glazer, John L. Wood and Zachary Pincus and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Demetrios T. Braddock

51 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

2014 961 citations Demetrios T. Braddock et al. profile →
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment

2014 683 citations Raman Bahal, Demetrios T. Braddock et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Demetrios T. Braddock United States	22	2.1k	584	391	389	286	53	2.8k
Joëlle Thillet France	32	1.3k 0.6×	756 1.3×	330 0.8×	557 1.4×	245 0.9×	97	3.2k
Paola Izzo Italy	28	1.3k 0.6×	513 0.9×	121 0.3×	338 0.9×	532 1.9×	117	2.6k
Koji Ueda Japan	37	2.7k 1.3×	898 1.5×	151 0.4×	329 0.8×	500 1.7×	129	3.9k
Ming‐Fong Lin United States	37	2.5k 1.2×	748 1.3×	349 0.9×	213 0.5×	938 3.3×	100	4.1k
Mark R. Wardell United States	24	1.7k 0.8×	964 1.7×	529 1.4×	684 1.8×	360 1.3×	36	3.3k
Ting Gui China	26	1.4k 0.6×	438 0.8×	118 0.3×	237 0.6×	333 1.2×	61	2.5k
Dimcho Bachvarov Canada	34	1.9k 0.9×	439 0.8×	198 0.5×	174 0.4×	582 2.0×	91	3.9k
Abdel‐Majid Khatib France	32	1.7k 0.8×	809 1.4×	164 0.4×	412 1.1×	1.0k 3.6×	96	3.4k
Adrie van Bokhoven United States	35	2.5k 1.2×	1.1k 1.8×	184 0.5×	379 1.0×	992 3.5×	74	4.6k
Sergei M. Danilov United States	36	1.7k 0.8×	212 0.4×	469 1.2×	291 0.7×	391 1.4×	123	3.7k

Countries citing papers authored by Demetrios T. Braddock

Since Specialization

Citations

This map shows the geographic impact of Demetrios T. Braddock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demetrios T. Braddock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demetrios T. Braddock more than expected).

Fields of papers citing papers by Demetrios T. Braddock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Demetrios T. Braddock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Demetrios T. Braddock. The network helps show where Demetrios T. Braddock may publish in the future.

Co-authorship network of co-authors of Demetrios T. Braddock

This figure shows the co-authorship network connecting the top 25 collaborators of Demetrios T. Braddock. A scholar is included among the top collaborators of Demetrios T. Braddock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Demetrios T. Braddock. Demetrios T. Braddock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Srivastava, Shivani, Simon von Kroge, Paul R. Stabach, et al.. (2025). Improvements in hearing loss with bone-targeted enzyme replacement therapy are associated with corrected hypomineralization and osteocyte properties of auditory ossicles in Enpp1-deficient mice. Journal of Bone and Mineral Research. 40(9). 1077–1086.

Stabach, Paul R., et al.. (2024). Novel treatment for PXE: Recombinant ENPP1 enzyme therapy. Molecular Therapy. 32(11). 3815–3820. 4 indexed citations

Katô, Hajime, Yasuhisa Ohata, Yuka Kinoshita, et al.. (2024). Effect of Mutation Type on Ectopic Ossification Among Adult Patients With X-Linked Hypophosphatemia. Journal of the Endocrine Society. 8(12). bvae184–bvae184. 2 indexed citations

Ferreira, Carlos R., Thomas O. Carpenter, & Demetrios T. Braddock. (2023). ENPP1 in Blood and Bone: Skeletal and Soft Tissue Diseases Induced by ENPP1 Deficiency. Annual Review of Pathology Mechanisms of Disease. 19(1). 507–540. 18 indexed citations

Murtada, Sae‐Il, Mo Wang, Yuki I. Kawamura, et al.. (2023). Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome. eLife. 12. 11 indexed citations

Tang, Haiming, Gauri Panse, Demetrios T. Braddock, et al.. (2023). IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression. Journal of Cutaneous Pathology. 50(7). 595–600. 3 indexed citations

Katô, Hajime, Demetrios T. Braddock, & Nobuaki Ito. (2023). Genetics of Diffuse Idiopathic Skeletal Hyperostosis and Ossification of the Spinal Ligaments. Current Osteoporosis Reports. 21(5). 552–566. 9 indexed citations

Stabach, Paul R., et al.. (2022). Strategies for Glycoengineering Therapeutic Proteins. Frontiers in Chemistry. 10. 863118–863118. 41 indexed citations

Liu, Yanfeng, Elias Quijano, Eric Song, et al.. (2021). Direct targeting of amplified gene loci for proapoptotic anticancer therapy. Nature Biotechnology. 40(3). 325–334. 21 indexed citations

10.

Murtada, Sae‐Il, Yuki I. Kawamura, Alexander W. Caulk, et al.. (2020). Paradoxical aortic stiffening and subsequent cardiac dysfunction in Hutchinson–Gilford progeria syndrome. Journal of The Royal Society Interface. 17(166). 20200066–20200066. 18 indexed citations

11.

Malik, Shipra, Jihoon Lim, Frank J. Slack, Demetrios T. Braddock, & Raman Bahal. (2020). Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles. Journal of Controlled Release. 327. 406–419. 39 indexed citations

12.

Chu, Emily Y., Tam Vo, M.B. Chavez, et al.. (2020). Genetic and pharmacologic modulation of cementogenesis via pyrophosphate regulators. Bone. 136. 115329–115329. 14 indexed citations

13.

Katô, Hajime, Yuka Kinoshita, Yuki Taniguchi, et al.. (2020). Identification of ENPP1 Haploinsufficiency in Patients With Diffuse Idiopathic Skeletal Hyperostosis and Early-Onset Osteoporosis. Journal of Bone and Mineral Research. 37(6). 1125–1135. 27 indexed citations

14.

Caballero, Daniel, et al.. (2017). Intraperitoneal pyrophosphate treatment reduces renal calcifications in Npt2a null mice. PLoS ONE. 12(7). e0180098–e0180098. 6 indexed citations

15.

Braddock, Demetrios T.. (2010). Autotaxin and lipid signaling pathways as anticancer targets.. PubMed. 11(6). 629–37. 9 indexed citations

16.

Li, Shuangwei, Sergei A. Ezhevsky, Matthew H. Cato, et al.. (2010). Radiation Sensitivity and Tumor Susceptibility in ATM Phospho-Mutant ATF2 Mice. Genes & Cancer. 1(4). 316–330. 18 indexed citations

17.

Saunders, Lauren P., et al.. (2008). Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion. Molecular Cancer Therapeutics. 7(10). 3352–3362. 61 indexed citations

18.

Huth, Jeffrey R., Liping Yu, Irene Collins, et al.. (2004). NMR-Driven Discovery of Benzoylanthranilic Acid Inhibitors of Far Upstream Element Binding Protein Binding to the Human Oncogene c-myc Promoter. Journal of Medicinal Chemistry. 47(20). 4851–4857. 32 indexed citations

19.

Caffrey, Michael, Demetrios T. Braddock, John M. Louis, et al.. (2000). Biophysical Characterization of gp41 Aggregates Suggests a Model for the Molecular Mechanism of HIV-associated Neurological Damage and Dementia. Journal of Biological Chemistry. 275(26). 19877–19882. 25 indexed citations

20.

Pennec, P.Y. Le, Pierre Gane, F. Noizat‐Pirenne, et al.. (1996). Flow cytometric evaluation of non anti-RH1(D) monoclonal Rh antibodies. Transfusion Clinique et Biologique. 3(6). 433–435. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact